A Comparison Of Cardiovascular Benefits Of Dapagliflozin And Empagliflozin In Type 2 Diabetes: A Systematic Review And Meta-analysis

20260 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Cardiac Failure

Volume 32, Issue 1, pp. 318-319

Field-Weighted Citation Impact: 0.00